NEW YORK, Nov. 12 /PRNewswire/ -- Val Bias, Chief Executive Officer of the National Hemophilia Foundation is featured in the November 2008 issue of Black Enterprise magazine in the "On the Move" section of the Powerplay Department. The department highlights African-American men and women who have been appointed to new management positions in the upper echelons of the corporate world. Recent announcements have included leadership posts at BET, MTV and Northrop Grumman.
Black Enterprise magazine is a monthly business publication for African-American professionals and entrepreneurs. It has a paid circulation of 525,000, with approximately 4.3 million readers. The magazine is available online at: http://www.blackenterprise.com.
Bias joined the National Hemophilia Foundation as Chief Executive Officer in May 2008 after the board searched for candidates that exemplified quality leadership in the bleeding and clotting disorders community. Mr. Bias is also the first African-American to serve as CEO in NHF's 50 year history.
A long history with NHF proves that Bias is a trusted leader, diplomatic manager and committed participant in the bleeding and clotting disorders community. For more than 28 years, he has served NHF as a volunteer, consultant, advocate and board chair in 1992.
In his position as CEO, Bias was immediately tasked with advancing a nationwide reorganization of the Foundation and the strategic positioning of the organization. Bias also promised to increase efforts on research and advocacy while using education as a key component.
Bias will be leading the NHF's 60th annual meeting in Denver, Colorado on November 13-15, 2008. The meeting is the largest in the country bringing together individuals and their families living with bleeding and clotting disorders -- healthcare providers -- community leaders and industry representatives.
"From an incredible base of candidates including aligned organization leaders, community advocates, associated sciences and businesses, Val Bias stood front and center as the best leader upon whom NHF and its constituents may solidly depend to lead this organization into the future," said Raymond Stanhope, Chair of the Board of Directors for the National Hemophilia Foundation. "Vision, dedication, clarity of purpose -- Val brings it all."
Approximately 400,000 people around the world have hemophilia. Hemophilia is an inherited bleeding disorder characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. The disease is caused by deficient or defective blood coagulation proteins, known as factor VIII or IX. The most common form of the disease is hemophilia A, or classic hemophilia, in which the clotting factor VIII is either deficient or defective. Hemophilia B is characterized by deficient or defective factor IX.
About the National Hemophilia Foundation
The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.
|SOURCE National Hemophilia Foundation|
Copyright©2008 PR Newswire.
All rights reserved